AQR Arbitrage’s AbbVie ABBV Stock Holding History

AQR Arbitrage’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,495	Closed	-$1M	–	975
2020 Q4	$1M	Buy	+9,495	New	+$912K	0.04%	438
2015 Q3	–	Sell	-60,219	Closed	-$4.05M	–	460
2015 Q2	$4.05M	Buy	+60,219	New	+$3.93M	0.05%	184

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Arbitrage's ABBV Position: Q1 2021 in Review

AQR Arbitrage sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 9,495 shares — an estimated $1M sold.

AQR Arbitrage first reported a position in ABBV in Q2 2015 and held it in 2 quarters. The position peaked at $4.05M in Q2 2015. 2,614 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

AQR Arbitrage reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
AQR Arbitrage sold 9,495 AbbVie shares in Q1 2021, an estimated $1M.
AQR Arbitrage first reported a position in AbbVie in Q2 2015 and held it in 2 quarters.
AQR Arbitrage's AbbVie position peaked at $4.05M in Q2 2015.
2,614 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.